nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A2—Vinblastine—testicular cancer	0.219	0.382	CbGbCtD
Disopyramide—SLC22A2—Cisplatin—testicular cancer	0.201	0.35	CbGbCtD
Disopyramide—CYP3A4—Ifosfamide—testicular cancer	0.0659	0.115	CbGbCtD
Disopyramide—CYP3A4—Vinblastine—testicular cancer	0.035	0.0609	CbGbCtD
Disopyramide—CYP3A4—Etoposide—testicular cancer	0.0315	0.0549	CbGbCtD
Disopyramide—CYP3A4—Doxorubicin—testicular cancer	0.0215	0.0374	CbGbCtD
Disopyramide—Body temperature increased—Bleomycin—testicular cancer	0.00105	0.00247	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—testicular cancer	0.00105	0.00247	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—testicular cancer	0.00105	0.00247	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00105	0.00245	CcSEcCtD
Disopyramide—Dizziness—Vinblastine—testicular cancer	0.00104	0.00245	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—testicular cancer	0.00103	0.00241	CcSEcCtD
Disopyramide—Feeling abnormal—Dactinomycin—testicular cancer	0.00102	0.0024	CcSEcCtD
Disopyramide—Nausea—Chlorambucil—testicular cancer	0.00102	0.0024	CcSEcCtD
Disopyramide—Paraesthesia—Ifosfamide—testicular cancer	0.00102	0.0024	CcSEcCtD
Disopyramide—Ill-defined disorder—Etoposide—testicular cancer	0.00102	0.0024	CcSEcCtD
Disopyramide—Dyspnoea—Ifosfamide—testicular cancer	0.00101	0.00238	CcSEcCtD
Disopyramide—Somnolence—Ifosfamide—testicular cancer	0.00101	0.00237	CcSEcCtD
Disopyramide—Discomfort—Cisplatin—testicular cancer	0.00101	0.00237	CcSEcCtD
Disopyramide—Vomiting—Vinblastine—testicular cancer	0.001	0.00235	CcSEcCtD
Disopyramide—Malaise—Etoposide—testicular cancer	0.000993	0.00233	CcSEcCtD
Disopyramide—Vertigo—Etoposide—testicular cancer	0.00099	0.00232	CcSEcCtD
Disopyramide—Decreased appetite—Ifosfamide—testicular cancer	0.000989	0.00232	CcSEcCtD
Disopyramide—Headache—Vinblastine—testicular cancer	0.000988	0.00232	CcSEcCtD
Disopyramide—Body temperature increased—Dactinomycin—testicular cancer	0.000982	0.0023	CcSEcCtD
Disopyramide—Fatigue—Ifosfamide—testicular cancer	0.000981	0.0023	CcSEcCtD
Disopyramide—Oedema—Cisplatin—testicular cancer	0.000981	0.0023	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—testicular cancer	0.000975	0.00229	CcSEcCtD
Disopyramide—Pain—Ifosfamide—testicular cancer	0.000973	0.00228	CcSEcCtD
Disopyramide—Constipation—Ifosfamide—testicular cancer	0.000973	0.00228	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—testicular cancer	0.000972	0.00228	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—testicular cancer	0.000972	0.00228	CcSEcCtD
Disopyramide—Loss of consciousness—Etoposide—testicular cancer	0.000968	0.00227	CcSEcCtD
Disopyramide—Thrombocytopenia—Cisplatin—testicular cancer	0.000961	0.00225	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—testicular cancer	0.00096	0.00225	CcSEcCtD
Disopyramide—Asthenia—Bleomycin—testicular cancer	0.000956	0.00224	CcSEcCtD
Disopyramide—Skin disorder—Cisplatin—testicular cancer	0.000953	0.00224	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—testicular cancer	0.000949	0.00223	CcSEcCtD
Disopyramide—Hyperhidrosis—Cisplatin—testicular cancer	0.000949	0.00223	CcSEcCtD
Disopyramide—Pruritus—Bleomycin—testicular cancer	0.000942	0.00221	CcSEcCtD
Disopyramide—Feeling abnormal—Ifosfamide—testicular cancer	0.000938	0.0022	CcSEcCtD
Disopyramide—Chest pain—Etoposide—testicular cancer	0.000938	0.0022	CcSEcCtD
Disopyramide—Nausea—Vinblastine—testicular cancer	0.000937	0.0022	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—testicular cancer	0.000936	0.0022	CcSEcCtD
Disopyramide—Anorexia—Cisplatin—testicular cancer	0.000935	0.0022	CcSEcCtD
Disopyramide—Hypokalaemia—Epirubicin—testicular cancer	0.000933	0.00219	CcSEcCtD
Disopyramide—Discomfort—Etoposide—testicular cancer	0.000926	0.00217	CcSEcCtD
Disopyramide—Hypotension—Cisplatin—testicular cancer	0.000917	0.00215	CcSEcCtD
Disopyramide—Confusional state—Etoposide—testicular cancer	0.000906	0.00213	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—testicular cancer	0.000904	0.00212	CcSEcCtD
Disopyramide—Urticaria—Ifosfamide—testicular cancer	0.000904	0.00212	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—testicular cancer	0.000902	0.00212	CcSEcCtD
Disopyramide—Body temperature increased—Ifosfamide—testicular cancer	0.0009	0.00211	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—testicular cancer	0.000892	0.00209	CcSEcCtD
Disopyramide—Asthenia—Dactinomycin—testicular cancer	0.000891	0.00209	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—testicular cancer	0.000889	0.00209	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—testicular cancer	0.000885	0.00208	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—testicular cancer	0.000885	0.00208	CcSEcCtD
Disopyramide—Paraesthesia—Cisplatin—testicular cancer	0.000881	0.00207	CcSEcCtD
Disopyramide—Thrombocytopenia—Etoposide—testicular cancer	0.00088	0.00207	CcSEcCtD
Disopyramide—Dyspnoea—Cisplatin—testicular cancer	0.000875	0.00205	CcSEcCtD
Disopyramide—Skin disorder—Etoposide—testicular cancer	0.000873	0.00205	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—testicular cancer	0.000872	0.00205	CcSEcCtD
Disopyramide—Hyperhidrosis—Etoposide—testicular cancer	0.000869	0.00204	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—testicular cancer	0.000866	0.00203	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—testicular cancer	0.000863	0.00203	CcSEcCtD
Disopyramide—Anorexia—Etoposide—testicular cancer	0.000857	0.00201	CcSEcCtD
Disopyramide—Decreased appetite—Cisplatin—testicular cancer	0.000853	0.002	CcSEcCtD
Disopyramide—Diarrhoea—Dactinomycin—testicular cancer	0.00085	0.00199	CcSEcCtD
Disopyramide—Vomiting—Bleomycin—testicular cancer	0.000847	0.00199	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—testicular cancer	0.000844	0.00198	CcSEcCtD
Disopyramide—Depression—Methotrexate—testicular cancer	0.000842	0.00198	CcSEcCtD
Disopyramide—Hypotension—Etoposide—testicular cancer	0.00084	0.00197	CcSEcCtD
Disopyramide—Rash—Bleomycin—testicular cancer	0.00084	0.00197	CcSEcCtD
Disopyramide—Pain—Cisplatin—testicular cancer	0.000839	0.00197	CcSEcCtD
Disopyramide—Dermatitis—Bleomycin—testicular cancer	0.000839	0.00197	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—testicular cancer	0.000837	0.00196	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—testicular cancer	0.000829	0.00194	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—testicular cancer	0.000829	0.00194	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—testicular cancer	0.000825	0.00194	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—testicular cancer	0.000819	0.00192	CcSEcCtD
Disopyramide—Asthenia—Ifosfamide—testicular cancer	0.000817	0.00192	CcSEcCtD
Disopyramide—Feeling abnormal—Cisplatin—testicular cancer	0.000809	0.0019	CcSEcCtD
Disopyramide—Paraesthesia—Etoposide—testicular cancer	0.000807	0.00189	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—testicular cancer	0.000806	0.00189	CcSEcCtD
Disopyramide—Pruritus—Ifosfamide—testicular cancer	0.000805	0.00189	CcSEcCtD
Disopyramide—Dyspnoea—Etoposide—testicular cancer	0.000801	0.00188	CcSEcCtD
Disopyramide—Somnolence—Etoposide—testicular cancer	0.000799	0.00188	CcSEcCtD
Disopyramide—Nausea—Bleomycin—testicular cancer	0.000791	0.00186	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—testicular cancer	0.00079	0.00185	CcSEcCtD
Disopyramide—Vomiting—Dactinomycin—testicular cancer	0.00079	0.00185	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—testicular cancer	0.000788	0.00185	CcSEcCtD
Disopyramide—Rash—Dactinomycin—testicular cancer	0.000783	0.00184	CcSEcCtD
Disopyramide—Decreased appetite—Etoposide—testicular cancer	0.000781	0.00183	CcSEcCtD
Disopyramide—Diarrhoea—Ifosfamide—testicular cancer	0.000779	0.00183	CcSEcCtD
Disopyramide—Body temperature increased—Cisplatin—testicular cancer	0.000776	0.00182	CcSEcCtD
Disopyramide—Fatigue—Etoposide—testicular cancer	0.000775	0.00182	CcSEcCtD
Disopyramide—Pain—Etoposide—testicular cancer	0.000769	0.0018	CcSEcCtD
Disopyramide—Constipation—Etoposide—testicular cancer	0.000769	0.0018	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—testicular cancer	0.000767	0.0018	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—testicular cancer	0.000767	0.0018	CcSEcCtD
Disopyramide—Hepatitis—Methotrexate—testicular cancer	0.000758	0.00178	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—testicular cancer	0.000757	0.00178	CcSEcCtD
Disopyramide—Dizziness—Ifosfamide—testicular cancer	0.000753	0.00177	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—testicular cancer	0.000746	0.00175	CcSEcCtD
Disopyramide—Feeling abnormal—Etoposide—testicular cancer	0.000741	0.00174	CcSEcCtD
Disopyramide—Nausea—Dactinomycin—testicular cancer	0.000738	0.00173	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—testicular cancer	0.000737	0.00173	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—testicular cancer	0.000731	0.00172	CcSEcCtD
Disopyramide—Vomiting—Ifosfamide—testicular cancer	0.000724	0.0017	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—testicular cancer	0.000722	0.00169	CcSEcCtD
Disopyramide—Rash—Ifosfamide—testicular cancer	0.000718	0.00168	CcSEcCtD
Disopyramide—Dermatitis—Ifosfamide—testicular cancer	0.000717	0.00168	CcSEcCtD
Disopyramide—Urticaria—Etoposide—testicular cancer	0.000714	0.00168	CcSEcCtD
Disopyramide—Body temperature increased—Etoposide—testicular cancer	0.000711	0.00167	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—testicular cancer	0.000709	0.00166	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—testicular cancer	0.000706	0.00166	CcSEcCtD
Disopyramide—Asthenia—Cisplatin—testicular cancer	0.000704	0.00165	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—testicular cancer	0.000682	0.0016	CcSEcCtD
Disopyramide—Nausea—Ifosfamide—testicular cancer	0.000676	0.00159	CcSEcCtD
Disopyramide—Diarrhoea—Cisplatin—testicular cancer	0.000671	0.00158	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—testicular cancer	0.000668	0.00157	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—testicular cancer	0.000656	0.00154	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—testicular cancer	0.000653	0.00153	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—testicular cancer	0.000646	0.00152	CcSEcCtD
Disopyramide—Asthenia—Etoposide—testicular cancer	0.000645	0.00151	CcSEcCtD
Disopyramide—Pruritus—Etoposide—testicular cancer	0.000636	0.00149	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—testicular cancer	0.000634	0.00149	CcSEcCtD
Disopyramide—Vomiting—Cisplatin—testicular cancer	0.000624	0.00146	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—testicular cancer	0.000622	0.00146	CcSEcCtD
Disopyramide—Rash—Cisplatin—testicular cancer	0.000619	0.00145	CcSEcCtD
Disopyramide—Dermatitis—Cisplatin—testicular cancer	0.000618	0.00145	CcSEcCtD
Disopyramide—Diarrhoea—Etoposide—testicular cancer	0.000615	0.00144	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—testicular cancer	0.000612	0.00144	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—testicular cancer	0.000608	0.00143	CcSEcCtD
Disopyramide—Tension—Epirubicin—testicular cancer	0.000606	0.00142	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—testicular cancer	0.000605	0.00142	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—testicular cancer	0.0006	0.00141	CcSEcCtD
Disopyramide—Malaise—Methotrexate—testicular cancer	0.000595	0.0014	CcSEcCtD
Disopyramide—Dizziness—Etoposide—testicular cancer	0.000594	0.0014	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—testicular cancer	0.000593	0.00139	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—testicular cancer	0.000586	0.00138	CcSEcCtD
Disopyramide—Nausea—Cisplatin—testicular cancer	0.000583	0.00137	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—testicular cancer	0.000582	0.00137	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—testicular cancer	0.000573	0.00134	CcSEcCtD
Disopyramide—Vomiting—Etoposide—testicular cancer	0.000572	0.00134	CcSEcCtD
Disopyramide—Rash—Etoposide—testicular cancer	0.000567	0.00133	CcSEcCtD
Disopyramide—Dermatitis—Etoposide—testicular cancer	0.000566	0.00133	CcSEcCtD
Disopyramide—Headache—Etoposide—testicular cancer	0.000563	0.00132	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—testicular cancer	0.000563	0.00132	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—testicular cancer	0.000562	0.00132	CcSEcCtD
Disopyramide—Tension—Doxorubicin—testicular cancer	0.000561	0.00132	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—testicular cancer	0.000559	0.00131	CcSEcCtD
Disopyramide—Malaise—Epirubicin—testicular cancer	0.000557	0.00131	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—testicular cancer	0.000555	0.0013	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—testicular cancer	0.000555	0.0013	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—testicular cancer	0.000555	0.0013	CcSEcCtD
Disopyramide—Syncope—Epirubicin—testicular cancer	0.000554	0.0013	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—testicular cancer	0.000543	0.00127	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—testicular cancer	0.000543	0.00127	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—testicular cancer	0.000538	0.00126	CcSEcCtD
Disopyramide—Nausea—Etoposide—testicular cancer	0.000534	0.00125	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—testicular cancer	0.00053	0.00124	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—testicular cancer	0.000527	0.00124	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—testicular cancer	0.000526	0.00123	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—testicular cancer	0.000523	0.00123	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—testicular cancer	0.000521	0.00122	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—testicular cancer	0.000519	0.00122	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—testicular cancer	0.000515	0.00121	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—testicular cancer	0.000514	0.00121	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—testicular cancer	0.000513	0.0012	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—testicular cancer	0.000513	0.0012	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—testicular cancer	0.000512	0.0012	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—testicular cancer	0.000508	0.00119	CcSEcCtD
Disopyramide—Oedema—Epirubicin—testicular cancer	0.000504	0.00118	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—testicular cancer	0.000503	0.00118	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—testicular cancer	0.000502	0.00118	CcSEcCtD
Disopyramide—Shock—Epirubicin—testicular cancer	0.000496	0.00116	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—testicular cancer	0.000493	0.00116	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—testicular cancer	0.000489	0.00115	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—testicular cancer	0.000487	0.00114	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—testicular cancer	0.000487	0.00114	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—testicular cancer	0.000486	0.00114	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—testicular cancer	0.000483	0.00113	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—testicular cancer	0.000481	0.00113	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—testicular cancer	0.00048	0.00113	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—testicular cancer	0.00048	0.00113	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—testicular cancer	0.000479	0.00112	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—testicular cancer	0.000476	0.00112	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—testicular cancer	0.000474	0.00111	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—testicular cancer	0.000471	0.00111	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—testicular cancer	0.00047	0.0011	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—testicular cancer	0.000468	0.0011	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—testicular cancer	0.000466	0.00109	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—testicular cancer	0.000464	0.00109	CcSEcCtD
Disopyramide—Pain—Methotrexate—testicular cancer	0.00046	0.00108	CcSEcCtD
Disopyramide—Shock—Doxorubicin—testicular cancer	0.000459	0.00108	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000457	0.00107	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—testicular cancer	0.000456	0.00107	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—testicular cancer	0.000453	0.00106	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—testicular cancer	0.000452	0.00106	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000451	0.00106	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—testicular cancer	0.000449	0.00105	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—testicular cancer	0.000448	0.00105	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—testicular cancer	0.000444	0.00104	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—testicular cancer	0.000444	0.00104	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—testicular cancer	0.000444	0.00104	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—testicular cancer	0.000438	0.00103	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—testicular cancer	0.000436	0.00102	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—testicular cancer	0.000434	0.00102	CcSEcCtD
Disopyramide—Pain—Epirubicin—testicular cancer	0.000431	0.00101	CcSEcCtD
Disopyramide—Constipation—Epirubicin—testicular cancer	0.000431	0.00101	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—testicular cancer	0.000428	0.001	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—testicular cancer	0.000426	0.000999	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—testicular cancer	0.000422	0.00099	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—testicular cancer	0.000419	0.000983	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—testicular cancer	0.000416	0.000976	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—testicular cancer	0.000415	0.000974	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—testicular cancer	0.000414	0.000973	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—testicular cancer	0.00041	0.000963	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—testicular cancer	0.000405	0.000951	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—testicular cancer	0.000402	0.000943	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—testicular cancer	0.0004	0.000939	CcSEcCtD
Disopyramide—Pain—Doxorubicin—testicular cancer	0.000399	0.000936	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—testicular cancer	0.000399	0.000936	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—testicular cancer	0.000398	0.000935	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—testicular cancer	0.000386	0.000907	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—testicular cancer	0.000384	0.000902	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—testicular cancer	0.000381	0.000894	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—testicular cancer	0.00037	0.000869	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—testicular cancer	0.000369	0.000865	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—testicular cancer	0.000368	0.000865	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—testicular cancer	0.000362	0.000848	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—testicular cancer	0.000357	0.000837	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—testicular cancer	0.000356	0.000836	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—testicular cancer	0.000345	0.000809	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—testicular cancer	0.000342	0.000803	CcSEcCtD
Disopyramide—Rash—Methotrexate—testicular cancer	0.00034	0.000797	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—testicular cancer	0.000339	0.000796	CcSEcCtD
Disopyramide—Headache—Methotrexate—testicular cancer	0.000337	0.000792	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—testicular cancer	0.000335	0.000785	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—testicular cancer	0.000333	0.000782	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—testicular cancer	0.00033	0.000774	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—testicular cancer	0.00032	0.000752	CcSEcCtD
Disopyramide—Nausea—Methotrexate—testicular cancer	0.00032	0.000751	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—testicular cancer	0.000319	0.000749	CcSEcCtD
Disopyramide—Rash—Epirubicin—testicular cancer	0.000318	0.000746	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—testicular cancer	0.000317	0.000745	CcSEcCtD
Disopyramide—Headache—Epirubicin—testicular cancer	0.000316	0.000741	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—testicular cancer	0.000308	0.000724	CcSEcCtD
Disopyramide—Nausea—Epirubicin—testicular cancer	0.000299	0.000702	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—testicular cancer	0.000296	0.000696	CcSEcCtD
Disopyramide—Rash—Doxorubicin—testicular cancer	0.000294	0.00069	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—testicular cancer	0.000294	0.000689	CcSEcCtD
Disopyramide—Headache—Doxorubicin—testicular cancer	0.000292	0.000685	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—testicular cancer	0.000277	0.00065	CcSEcCtD
